Nuwan Nanayakkara

424 total citations
11 papers, 326 citations indexed

About

Nuwan Nanayakkara is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nuwan Nanayakkara has authored 11 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nuwan Nanayakkara's work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Nuwan Nanayakkara is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Nuwan Nanayakkara collaborates with scholars based in United States, France and Belgium. Nuwan Nanayakkara's co-authors include Janice Armstrong, Burnett S. Kelly, Mary Ann Miller, Sue C. Heffelfinger, Prabir Roy‐Chaudhury, Noel Cressie, David L. Denman, Howard R. Elson, Benjamin Wu and Hans Wildiers and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Kidney International.

In The Last Decade

Nuwan Nanayakkara

11 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nuwan Nanayakkara United States	4	229	200	145	86	36	11	326
Janice Armstrong United States	4	278 1.2×	244 1.2×	187 1.3×	95 1.1×	51 1.4×	6	370
Marwan Tabbara United States	12	320 1.4×	232 1.2×	201 1.4×	88 1.0×	10 0.3×	37	421
Yoichi Muto Japan	11	24 0.1×	144 0.7×	206 1.4×	12 0.1×	23 0.6×	29	361
Nayan Sivamurthy United States	11	77 0.3×	364 1.8×	199 1.4×	25 0.3×	18 0.5×	16	458
Mireille A. Moise United States	9	109 0.5×	268 1.3×	264 1.8×	2 0.0×	13 0.4×	11	467
Franco Decian Italy	8	23 0.1×	130 0.7×	239 1.6×	8 0.1×	10 0.3×	23	429
Danielle M. Pineda United States	8	21 0.1×	139 0.7×	135 0.9×	7 0.1×	7 0.2×	27	310
Roberto Minici Italy	11	43 0.2×	114 0.6×	132 0.9×	3 0.0×	3 0.1×	38	303
Wolfgang Sperker Austria	9	10 0.0×	57 0.3×	144 1.0×	18 0.2×	2 0.1×	26	284
Yen‐Yang Chen Taiwan	9	22 0.1×	126 0.6×	79 0.5×	9 0.1×		20	210

Countries citing papers authored by Nuwan Nanayakkara

Since Specialization

Citations

This map shows the geographic impact of Nuwan Nanayakkara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuwan Nanayakkara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuwan Nanayakkara more than expected).

Fields of papers citing papers by Nuwan Nanayakkara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuwan Nanayakkara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuwan Nanayakkara. The network helps show where Nuwan Nanayakkara may publish in the future.

Co-authorship network of co-authors of Nuwan Nanayakkara

This figure shows the co-authorship network connecting the top 25 collaborators of Nuwan Nanayakkara. A scholar is included among the top collaborators of Nuwan Nanayakkara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuwan Nanayakkara. Nuwan Nanayakkara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kaufman, Peter A., Hans Wildiers, Gilles Freyer, et al.. (2018). Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer. Clinical Breast Cancer. 19(1). 47–57. 6 indexed citations

Ralapanawa, Udaya, et al.. (2018). Analysis and identification of symptoms and risk factors in a cohort of chronic hypertensive patients in a tertiary care hospital in Sri Lanka. Clinical and Experimental Hypertension. 41(5). 409–413. 3 indexed citations

Freyer, Gilles, Isabelle Ray‐Coquard, Dorothea Fischer, et al.. (2016). Routine Clinical Practice for Patients With Recurrent Ovarian Carcinoma. International Journal of Gynecological Cancer. 26(2). 240–247. 3 indexed citations

Kaufman, Peter A., Gilles Freyer, Margaret Kemeny, et al.. (2015). Abstract P5-19-14: A phase 1b study of trebananib plus paclitaxel and trastuzumab or capecitabine and lapatinib in patients with HER2+ locally recurrent or metastatic breast cancer. Cancer Research. 75(9_Supplement). P5–19. 1 indexed citations

Kaufman, Peter A., Gilles Freyer, Margaret Kemeny, et al.. (2014). A phase 1b study of trebananib plus paclitaxel (P) and trastuzumab (T) in patients (pts) with HER2+ locally recurrent or metastatic breast cancer (MBC).. Journal of Clinical Oncology. 32(15_suppl). 502–502. 2 indexed citations

Vergote, Ignace, Russell J. Schilder, Charles H. Pippitt, et al.. (2014). A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer. Gynecologic Oncology. 135(1). 25–33. 15 indexed citations

Wong, Shirley, Sumitra Ananda, Ignace Vergote, et al.. (2012). A PHASE 1B STUDY OF TREBANANIB (AMG 386) IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) OR TOPOTECAN (T) IN WOMEN WITH RECURRENT OVARIAN CANCER. Asia-Pacific Journal of Clinical Oncology. 8. 316–317. 1 indexed citations

Wildiers, Hans, Anthony Gonçalvès, Margaret Kemeny, et al.. (2012). Phase Ib study of open-label AMG 386 plus paclitaxel (P) and trastuzumab (T) or capecitabine (C) and lapatinib (L) in patients (pts) with HER2+ locally recurrent or metastatic breast cancer (MBC).. Journal of Clinical Oncology. 30(15_suppl). 529–529. 2 indexed citations

Kelly, Burnett S., Sue C. Heffelfinger, David L. Denman, et al.. (2002). External beam radiation attenuates venous neointimal hyperplasia in a pig model of arteriovenous polytetrafluoroethylene (PTFE) graft stenosis. International Journal of Radiation Oncology*Biology*Physics. 54(1). 263–269. 23 indexed citations

10.

Roy‐Chaudhury, Prabir, Burnett S. Kelly, Mary Ann Miller, et al.. (2001). Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney International. 59(6). 2325–2334. 267 indexed citations

11.

Nanayakkara, Nuwan & Noel Cressie. (1991). COMBINING TWO UNBIASED ESTIMATORS OF A COMMON MEAN OF TWO NORMAL POPULATIONS. Australian Journal of Statistics. 33(1). 43–56. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact